Dr Podcast Scripts for the Primary FRCA

1. Physiology: 1.1 Respiratory physiology; 1.1.1 Lung volumes and control of breathing; 1.1.2 Respiratory compliance and surface tension; 1.1.3 Ventilation, perfusion and dead-space; 1.1.4 Alveolar gas equation and shunt; 1.1.5 Pulmonary blood pressure and hypoxic pulmonary vasoconstriction; 1.1.6 Oxyhaemoglobin dissociation; 1.1.7 Altitude physiology; 1.2 Cardiovascular physiology; 1.2.1 Cardiac cycle; 1.2.2 Coronary circulation; 1.2.3 Pacemaker cells; 1.2.4 Valsalva manoeuvre; 1.2.5 Exercise physiology; 1.3 Physiology of the central, peripheral and autonomic nervous systems; 1.3.1 Cerebral circulation; 1.3.2 CSF; 1.3.3 Blood-brain barrier; 1.3.4 Action potentials; 1.3.5 Spinal cord; 1.3.6 Reflex arc; 1.3.7 The autonomic nervous system and adrenoceptors; 1.4 Physiology of the neuromuscular junction; 1.4.1 Neuromuscular junction; 1.4.2 Muscle physiology; 1.4.3 Pain pathways; 1.5 Fluids and renal physiology; 1.5.1 Fluid balance; 1.5.2 Acid-base physiology; 1.5.3 Renal physiology; 1.6 Liver and endocrine physiology; 1.6.1 Glucose and metabolism; 1.6.2 Pituitary and endocrine function; 1.6.3 Thyroid; 1.6.4 Adrenals; 1.6.5 Starvation and the stress response; 1.6.6 The liver and clotting; 1.6.7 Proteins and haemoglobin; 1.7 Immunology; 1.7.1 Immunology; 1.8 Pregnancy; 1.8.1 Physiological changes in pregnancy; 1.8.2 Maternal-fetal circulation; 2. Pharmacology: 2.1 Pharmacological principles; 2.1.1 Pharmacokinetics; 2.1.2 Pharmacodynamics; 2.1.3 Drug interactions; 2.1.4 Agonists and antagonists; 2.1.5 Isomerism; 2.1.6 Pharmacogenetics; 2.2 Intra-venous anaesthetic agents; 2.2.1 Propofol and thiopentone; 2.2.2 Ketamine and etomidate; 2.2.3 Rapid Sequence Induction; 2.3 Inhalational anaesthetic agents; 2.3.1 Inhalational agents; 2.3.2 MAC; 2.3.3 Nitrous oxide; 2.4 Neuromuscular blocking agents and anti-cholinesterase; 2.4.1 Neuromuscular blocking drugs; 2.4.2 Suxamethonium; 2.4.3 Anti-cholinesterases; 2.5 Local anaesthetics; 2.5.1 Local anaesthetics; 2.6 Analgesia agents; 2.6.1 Analgesic agents Dana L Kelly; 2.7 Drugs acting on the nervous system; 2.7.1 Anti-convulsants; 2.7.2 Benzodiazepines; 2.8 Drugs acting on the cardiovascular system; 2.8.1 Anti-hypertensive agents Caroline V Sampson and Samuel Nava; 2.8.2 Anti-arrhythmics; 2.8.3 Inotropes; 2.9 Drugs acting on the gastrointestinal tract; 2.9.1 Drugs acting on the GI tract; 2.9.2 Anti-emetics; 2.9.3 Hypoglycaemics; 2.10 Antibiotics; 2.10.1 Antibiotics; 2.11 Anti-coagulants; 2.11.1 Anti-coagulants; 2.12 Statistics; 2.12.1 Statistical data; 2.12.2 Statistical analysis; 2.13 Drugs used in major haemorrhage; 2.13.1 Tranexamic acid and drugs used in major haemorrhage; 3. Physics: 3.1 SI units; 3.1.1 SI units; 3.2 Biological signals and their measurement; 3.2.1 Biological signals; 3.2.2 Electrocardiogram; 3.2.3 Neuromuscular monitoring; 3.3 Gas flow and its measurement; 3.3.1 Gas laws; 3.3.2 Flow; 3.3.3 Measurement of gas volume and flow; 3.4 Gas supply and delivery; 3.4.1 Cylinders and gas supply; 3.4.2 Breathing systems; 3.4.3 Vaporisers Rebecca; 3.4.4 Soda lime and carbon dioxide absorption; 3.4.5 Scavenging systems; 3.5 Measurement of oxygen, carbon dioxide and anaesthetic agents; 3.5.1 Measurement of anaesthetic agents; 3.5.2 Oxygen measurement; 3.5.3 Pulse oximetry; 3.5.4 pH and CO2 measurement; 3.5.5 Capnography; 3.6 Temperature and humidity; 3.6.1 Heat loss; 3.6.2 Temperature and its measurement; 3.6.3 Humidification; 3.7 Pressure and cardiac output measurement; 3.7.1 Pressure measurement; 3.7.2 Blood pressure measurement; 3.7.3 Resonance and damping; 3.7.4 Intra-cranial pressure measurement; 3.7.5 Cardiac output measurement; 3.8 Electricity; 3.8.1 Electricity; 3.8.2 Electrical safety; 3.9 Equipment; 3.9.1 Defibrillators; 3.9.2 Lasers and diathermy; 3.9.3 Ultrasound.